Annexin A4: A novel molecular marker for gastric cancer with Helicobacter pylori infection using proteomics approach

Proteomics - Clinical Applications

Volumn 2, Issue 4, 2008, Pages 619-634

  Lin, Li Ling ^a   Chen, Chiung Nien ^a,b,c   Lin, Wei Chou ^b   Lee, Po Huang ^a,b   Chang, King Jen ^b   Lai, Yo Ping ^b   Wang, Jin Town ^b   Juan, Hsueh Fen ^a,d  

^a NATIONAL TAIWAN UNIVERSITY   (Taiwan)

^b NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

^c RESEARCH CENTER FOR APPLIED SCIENCES   (Taiwan)

^d Center for Systems Biology and Bioinformatics   (Taiwan)

Author keywords

2 DE; Annexin A4; Gastric cancer; Helicobactor pylori; Structure modeling

Indexed keywords

CALCIUM ION; CALMODULIN; CHLORIDE; INTERLEUKIN 8; LIPOCORTIN 2; LIPOCORTIN 4; MOLECULAR MARKER;

AMINO ACID SEQUENCE; ARTICLE; BINDING SITE; CANCER CELL; CANCER PATIENT; CANCER RISK; CHLORIDE CONDUCTANCE; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOKINE RELEASE; GASTRECTOMY; HELICOBACTER INFECTION; HELICOBACTER PYLORI; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN PROTEIN INTERACTION; PROTEIN STRUCTURE; PROTEOMICS; STOMACH CANCER; STOMACH CARCINOGENESIS; TANDEM MASS SPECTROMETRY; TUMOR VASCULARIZATION; TWO DIMENSIONAL ELECTROPHORESIS; WESTERN BLOTTING;

HELICOBACTER PYLORI;

EID: 42449098166     PISSN: 18628346     EISSN: None     Source Type: Journal    
DOI: 10.1002/prca.200780088     Document Type: Article

References (59)

1. Marshall, B. J., Warren, J. R., Unidentified curved bacilli in the stomach of patients with gastritis and peptic ulceration. Lancet 1984, 1, 1311-1315.
2. Schistosomes, liver flukes and Helicobacter pylori. IARC working group on the evaluation of carcinogenic risks to humans. Lyon, 7-14 June 1994. IARC Monogr. Eval. Carcinog. Risks Hum. 1994, 61, 1-241.
3. Wotherspoon, A. C., Doglioni, C., Diss, T. C., Pan, L. et al., Regression of primary low-grade B-cell gastric lymphoma of mucosa-associated lymphoid tissue type after eradication of Helicobacter pylori. Lancet 1993, 342, 575-577.
4. Bayerdorffer, E., Neubauer, A., Rudolph, B., Thiede, C. et al., Regression of primary gastric lymphoma of mucosa-associated lymphoid tissue type after cure of Helicobacter pylori infection. MALT Lymphoma Study Group. Lancet 1995, 345, 1591-1594.
5. Covacci, A., Telford, J. L., Del Giudice, G., Parsonnet, J., Rappuoli, R., Helicobacter pylori virulence and genetic geography. Science 1999, 284, 1328-1333.
6. Parsonnet, J., Friedman, G. D., Vandersteen, D. P., Chang, Y. et al., Helicobacter pylori infection and the risk of gastric carcinoma. N. Engl. J. Med. 1991, 325, 1127-1131.
7. Lin, J. T., Wang, L. Y., Wang, J. T., Wang, T. H. et al., A nested case-control study on the association between Helicobacter pylori infection and gastric cancer risk in a cohort of 9775 men in Taiwan. Anticancer Res. 1995, 15, 603-606.
8. Kelsen, D. P., Adjuvant and neoadjuvant therapy for gastric cancer. Semin. Oncol. 1996, 23, 379-389.
9. Wasinger, V. C., Cordwell, S. J., Cerpa-Poljak, A., Yan, J. X. et al., Progress with gene-product mapping of the Mollicutes: Mycoplasma genitalium. Etectrophoresis 1995, 16, 1090-1094.
10. Melle, C., Ernst, G., Schimmel, B., Bleul, A. et al., Characterization of pepsinogen C as a potential biomarker for gastric cancer using a histo-proteomic approach. J. Proteome Res. 2005, 4, 1799-1804.
11. Hsu, P. I., Chen, C. H., Hsieh, C. S., Chang, W. C. et al., Alpha1-antitrypsin precursor in gastric juice is a novel biomarker for gastric cancer and ulcer. Clin. Cancer Res. 2007, 13, 876-883.
12. Laemmli, U. K., Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 1970, 227, 680-685.
13. Onnerfjord, P., Ekstrom, S., Bergquist, J., Nilsson, J. et al., Homogeneous sample preparation for automated high throughput analysis with matrix-assisted laser desorption/ionisation time-of-flight mass spectrometry. Rapid Commun. Mass Spectrom. 1999, 13, 315-322.
14. Carr, S., Aebersold, R., Baldwin, M., Burlingame, A. et al., The need for guidelines in publication of peptide and protein identification data: Working group on publication guidelines for peptide and protein identification Data. Mol. Cell. Proteomics 2004, 3, 531-533.
15. Hsieh, P. F., Yang, J. C., Lin, J. T., Wang, J. T., Molecular mechanisms of clarithromycin resistance in Helicobacter pylori. J. Formos. Med. Assoc. 1998, 97, 445-452.
16. Tzeng, C. C., Meng, C. L., Jin, L., Hsieh, H. F., Cytogenetic studies of gastric adenocarcinoma. Cancer Genet. Cytogenet. 1991, 55, 67-71.
17. Guex, N., Peitsch, M. C., SWISS-MODEL and the Swiss-PdbViewer: An environment for comparative protein modeling. Electrophoresis 1997, 18, 2714-2723.
18. Goetz, M. P., Toft, D. O., Ames, M. M., Erlichman, C., The Hsp90 chaperone complex as a novel target for cancer therapy. Ann. Oncol. 2003, 14, 1169-1176.
19. Liu, X., Ye, L., Wang, J., Fan, D., Expression of heat shock protein 90 beta in human gastric cancer tissue and SGC7901/VCR of MDR-type gastric cancer cell line. Chin. Med. J. 1999, 112, 1133-1137.
20. Pihlajaniemi, T., Helaakoski, T., Tasanen, K., Myllyla, R. et al., Molecular cloning of the beta-subunit of human prolyl 4-hydroxylase. This subunit and protein disulphide isomerase are products of the same gene. EMBO J. 1987, 6, 643-649.
21. Sevier, C. S., Kaiser, C. A., Formation and transfer of disulphide bonds in living cells. Nat. Rev. Mol. Cell Biol. 2002, 3, 836-847.
22. Cai, H., Wang, C. C., Tsou, C. L., Chaperone-like activity of protein disulfide isomerase in the refolding of a protein with no disulfide bonds. J. Biol. Chem. 1994, 269, 24550-24552.
23. Jessop, C. E., Chakravarthi, S., Garbi, N., Hammerling, G. J. et al., ERp57 is essential for efficient folding of glycoproteins sharing common structural domains. EMBO J. 2007, 26, 28-40.
24. He, Q. Y., Cheung, Y. H., Leung, S. Y., Yuen, S. T. et al., Diverse proteomic alterations in gastric adenocarcinoma. Proteomics 2004, 4, 3276-3287.
25. Ryu, J. W., Kim, H. J., Lee, Y. S., Myong, N. H. et al., The proteomics approach to find biomarkers in gastric cancer. J. Korean Med. Sci. 2003, 18, 505-509.
26. Kolli, S., Zito, C. I., Mossink, M. H., Wiemer, E. A., Bennett, A. M., The major vault protein is a novel substrate for the tyrosine phosphatase SHP-2 and scaffold protein in epidermal growth factor signaling. J. Biol. Chem. 2004, 279, 29374-29385.
27. Suprenant, K. A., Vault ribonucleoprotein particles: sarcophagi, gondolas, or safety deposit boxes? Biochemistry 2002, 41, 14447-14454.
28. Mossink, M. H., van Zon, A., Scheper, R. J., Sonneveld, P., Wiemer, E. A., Vaults: A ribonucleoprotein particle involved in drug resistance? Oncogene 2003, 22, 7458-7467.
29. MacGillivray, R. T., Mendez, E., Sinha, S. K., Sutton, M. R. et al., The complete amino acid sequence of human serum transferrin. Proc. Natl. Acad. Sci. USA 1982, 79, 2504-2508.
30. Laskey, J., Webb, I., Schulman, H. M., Ponka, P., Evidence that transferrin supports cell proliferation by supplying iron for DNA synthesis. Exp. Cell Res. 1988, 176, 87-95.
31. Miles, L. A., Dahlberg, C. M., Plescia, J., Felez, J. et al., Role of cell-surface lysines in plasminogen binding to cells: identification of alpha-enolase as a candidate plasminogen receptor. Biochemistry 1991, 30, 1682-1691.
32. Takashima, M., Kuramitsu, Y., Yokoyama, Y., Iizuka, N. et al., Overexpression of alpha enolase in hepatitis C virus-related hepatocellular carcinoma: Association with tumor progression as determined by proteomic analysis. Proteomics 2005, 5, 1686-1692.
33. Hembrough, T. A., Li, L., Gonias, S. L., Cell-surface cytokeratin 8 is the major plasminogen receptor on breast cancer cells and is required for the accelerated activation of cell-associated plasminogen by tissue-type plasminogen activator. J. Biol. Chem. 1996, 271, 25684-25691.
34. Parkkila, S., Parkkila, A. K., Carbonic anhydrase in the alimentary tract. Roles of the different isozymes and salivary factors in the maintenance of optimal conditions in the gastrointestinal canal. Scand. J. Gastroenterol. 1996, 31, 305-317.
35. Bekku, S., Mochizuki, H., Yamamoto, T., Ueno, H. et al., Expression of carbonic anhydrase I or II and correlation to clinical aspects of colorectal cancer. Hepatogastroenterology 2000, 47, 998-1001.
36. Hyndman, D. J., Flynn, T. G., Sequence and expression levels in human tissues of a new member of the aldo-keto reductase family. Biochim. Biophys. Acta 1998, 1399, 198-202.
37. Scuric, Z., Stain, S. C., Anderson, W. F., Hwang, J. J., New member of aldose reductase family proteins overexpressed in human hepatocellular carcinoma. Hepatology 1998, 27, 943-950.
38. Penning, T. M., AKR1B10: A new diagnostic marker of non-small cell lung carcinoma in smokers. Clin. Cancer Res. 2005, 11, 1687-1690.
39. Bonafe, N., Gilmore-Hebert, M., Folk, N. L. Azodi, M. et al., Glyceraldehyde-3-phosphate dehydrogenase binds to the AU-Rich 3′ untranslated region of colony-stimulating factor-1 (CSF-1) messenger RNA in human ovarian cancer cells: Possible role in CSF-1 posttranscriptional regulation and tumor phenotype. Cancer Res. 2005, 65, 3762-3771.
40. Bae, S. M., Lee, C. H., Cho, Y. L., Nam, K. H. et al., Two-dimensional gel analysis of protein expression profile in squamous cervical cancer patients. Gynecol. Oncol. 2005, 99, 26-35.
41. Conlin, V. S., Curtis, S. B., Zhao, Y., Moore, E. D. et al., Helicobacter pylori infection targets adherens junction regulatory proteins and results in increased rates of migration in human gastric epithelial cells. Infect. Immun. 2004, 72, 5181-5192.
42. Emoto, K., Yamada, Y., Sawada, H., Fujimoto, H. et al., Annexin II overexpression correlates with stromal tenascin-C overexpression: A prognostic marker in colorectal carcinoma. Cancer 2001, 92, 1419-1426.
43. Han, E. K., Tahir, S. K., Cherian, S. P., Collins, N., Ng, S. C., Modulation of paclitaxel resistance by annexin IV in human cancer cell lines. Br. J. Cancer 2000, 83, 83-88.
44. Shi, T., Dong, F., Liou, L. S., Duan, Z. H. et al., Differential protein profiling in renal-cell carcinoma. Mol. Carcinog. 2004, 40, 47-61.
45. Satoh, A., Takayama, E., Kojima, K., Ogawa, H. et al., Expression of carbohydrate-binding protein p33/41 in human tumor cell lines. J. Biochem. 1996, 119, 346-353.
46. Das, S., Sierra, J. C., Soman, K. V., Suarez, G. et al., Differential protein expression profiles of gastric epithelial cells following Helicobacter pylori infection using ProteinChips. J. Proteome Res. 2005, 4, 920-930.
47. Kaetzel, M. A., Mo, Y. D., Mealy, T. R., Campos, B. et al., Phosphorylation mutants elucidate the mechanism of annexin IV-mediated membrane aggregation. Biochemistry 2001, 40, 4192-4199.
48. Sable, C. L., Riches, D. W., Cloning and functional activity of a novel truncated form of annexin IV in mouse macrophages. Biochem. Biophys. Res. Commun. 1999, 258, 162-167.
49. Emoto, K., Sawada, H., Yamada, Y., Fujimoto, H. et al., Annexin II overexpression is correlated with poor prognosis inhuman gastric carcinoma. Anticancer Res. 2001, 21, 1339-1345.
50. Beil, W., Birkholz, C., Wagner, S., Sewing, K. F., Helicobacter pylori fatty acid cis 9,10-methyleneoctadecanoic acid increases [Ca2+]i, activates protein kinase C and stimulates acid secretion in parietal cells. Prostaglandins Leukot. Eessent. Fatty Acids 1998, 59, 119-125.
51. Crabtree, J. E., Farmery, S. M., Lindley, I. J., Figura, N. et al., CagA/cytotoxic strains of Helicobacter pylori and interleukin-8 in gastric epithelial cell lines. J. Clin. Pathol. 1994, 47, 945-950.
52. Dreier, R., Schmid, K. W., Gerke, V., Riehemann, K., Differential expression of annexins I, II and IV in human tissues: an immunohistochemical study. Histochem. Cell Biol. 1998, 110, 137-148.
53. Piljic, A., Schultz, C., Annexin A4 self-association modulates general membrane protein mobility in living cells. Mol. Biol. Cell 2006, 17, 3318-3328.
54. Beil, W., Obst, B., Wagner, S., Sewing, K. F., The Helicobacter pylori fatty acid cis-9,10-methyleneoctadecanoic acid stimulates protein kinase C and increases DNA synthesis of gastric HM02 cells. Br. J. Cancer 1998, 77, 1852-1856.
55. Fuller, C. M., Benos, D. J., Ca(2+)-activated Cl(-) channels: A newly emerging anion transport family. News Physiol. Sci. 2000, 15, 165-171.
56. Gruber, A. D., Pauli, B. U., Tumorigenicity of human breast cancer is associated with loss of the Ca2+-activated chloride channel CLCA2. Cancer Res. 1999, 59, 5488-5491.
57. Nozawa, Y., Nishihara, K., Akizawa, Y., Orimoto, N. et al., Protein kinase C activation by Helicobacter pylori in human gastric epithelial cells limits interleukin-8 production through suppression of extracellular signal-regulated kinase. J. Pharmacol. Sci. 2004, 94, 233-239.
58. Li, A., Dubey, S., Varney, M. L., Dave, B. J., Singh, R. K., IL-8 directly enhanced endothelial cell survival, proliferation, and matrix metalloproteinases production and regulated angiogenesis. J. Immunol. 2003, 170, 3369-3376.
59. Ohkawa, H., Sohma, H., Sakai, R., Kuroki, Y. et al., Ethanol-induced augmentation of annexin IV in cultured cells and the enhancement of cytotoxicity by overexpression of annexin IV by ethanol. Biochim. Biophys. Acta 2002, 1588, 217-225.